|
|
Article: New Data Demonstrate ZOMIG(R) (zolmitriptan) Nasal Spray Provides Fast and Lasting Migraine Relief; Patients Report High Levels of Satisfaction with Nasal Spray Formulation.
- Article from:
- PR Newswire
- Article date:
- April 27, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Results of a new multicenter U.S. study of almost 1,900 patients experiencing more than 3,400 migraine attacks confirm that treatment with ZOMIG(R) (zolmitriptan) Nasal Spray provides a very fast onset of action and long-lasting relief from migraine headache and associated symptoms. Findings from an open-label trial also presented today demonstrate that patients are satisfied with the migraine relief received from ZOMIG Nasal Spray, with the majority of patients willing to continue its use. Data were presented today at the American Academy of Neurology (AAN) 56th Annual Meeting.
"Many migraine sufferers typically cite fast-acting relief as a high priority in ...